Clinical Infectious Diseases Publishes
“A Snapshot of Work by the COVID-19 Public Health Response”

Since early 2020, U.S. federal, state, and local public health agencies and personnel have been focusing their highest effort on the COVID-19 pandemic response. As vaccination levels in the United States increase and new variants are identified, a Clinical Infectious Diseases supplement takes a look back at the public health response to COVID-19 and what can be learned and built upon during the next phase of this pandemic and for future pandemics.

The supplement, “A Snapshot of Work by the COVID-19 Public Health Response,” provides a look at some of the science and experience involved in supporting the response.

Papers in the supplement include:

  • Evidence, experience, expertise, and the U.S. COVID-19 public health response
Clinical Sequelae of SARS-CoV-2 Infection
  • Late conditions diagnosed 1–4 months following an initial COVID-19 encounter: a matched cohort study using inpatient and outpatient administrative data — United States, March 1–June 30, 2020
  • Risk factors for illness severity among pregnant women with confirmed SARS-CoV-2 infection – Surveillance for Emerging Threats to Mothers and Babies Network, 22 state, local, and territorial health departments, March 29, 2020–March 5, 2021
  • Adverse pregnancy outcomes, maternal complications, and severe illness among U.S. delivery hospitalizations with and without a COVID-19 diagnosis
  • Adults hospitalized with COVID-19—United States, March-June and October-December 2020: Implications for the potential effects of COVID-19 tier-1 vaccination on future hospitalizations and outcomes
SARS-CoV-2 Testing
  • Results of a shortened quarantine protocol on a Midwestern college campus
  • COVID-19 mitigation efforts and testing during a survey training — Uganda, October 12–29, 2020
  • SARS-CoV-2 transmission in intercollegiate athletics not fully mitigated with daily antigen testing
  • Performance of repeat BinaxNOW SARS-CoV-2 antigen testing in a community setting, Wisconsin, November–December 2020
  • A comparison of less invasive SARS-CoV-2 diagnostic specimens in nursing home residents — Arkansas, June–August 2020
  • SARS-CoV-2 detection on self-collected saliva or anterior nasal specimens compared with healthcare personnel-collected nasopharyngeal specimens
COVID-19 and Other Infectious Diseases
  • Delayed tuberculosis diagnoses during the COVID-19 pandemic in 2020 — King County, Washington
  • Investigation of a suspect SARS-CoV-2 and influenza A mixed outbreak: Lessons learned for long-term care facilities nationwide
COVID-19 and Disproportionately Affected Persons
  • COVID-19 outbreaks at two construction sites — New York City, October–November 2020
  • Changes in emergency medical services before and during COVID-19 in the United States, January 2018–December 2020
  • Influenza vaccination in health centers during the COVID-19 pandemic—United States, November 7–27, 2020
  • Building a virtual global knowledge network during COVID-19: The Infection Prevention and Control Global Webinar Series
SARS-CoV-2 Transmission
  • Widespread SARS-CoV-2 transmission among attendees at a large motorcycle rally and their contacts, 30 U.S. jurisdictions, August–September 2020
  • Changes in seasonal respiratory illnesses in the United States during the COVID-19 pandemic
The Emergency Risk Communication Branch in the Division of Emergency Operations, Center for Preparedness and Response is responsible for the management of all COCA Products. 
For information about this update or other clinical issues, or to send your feedback, please contact us at
Clinician Outreach and Communication Activity—resources for healthcare providers
COCA RSS Feed—subscribe to be notified of conference calls, updates, and CDC guidance for health providers
Crisis & Emergency Risk Communication Training—training program that draws from lessons learned during public health emergencies, and incorporates best practices from the fields of risk and crisis communication
Health Alert Network—CDC's primary method of sharing cleared information about urgent public health incidents with public information officers; federal, state, territorial, and local public health practitioners; clinicians; and public health laboratories

CDC and HHS logos are the exclusive property of the Department of Health and Human Services and may not be used for any purpose without prior express written permission. Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.

Links to non-federal organizations are provided solely as a service to our users. Links do not constitute an endorsement of any organization by CDC or the federal government, and none should be inferred. CDC is not responsible for the content of the individual organizations.

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  |  Unsubscribe